Business
Investor presentation
Investor presentation.
About this update from Fusion Antibodies Plc
[{"type":"text","content":"\n\n \nREACH - Non-regulatory announcement*\n \n8 May 2025\n \nFusion Antibodies plc\n(\"Fusion\" or the \"Company\")\n \nInvestor presentation\n \nFusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that it will host an online live presentation on Thursday, 22 May at 11.30am, delivered by Dr Adrian Kinkaid, CEO and Stephen Smyth, interim CFO to accompany the recent trading update. The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management, who will discuss the recent trading update for FY 2025.\n \nThe presentation will be hosted through the digital platform Investor Meet Company (\"IMC\").\n \nInvestors can sign up to Investor Meet Company for free and add to meet Fusion Antibodies plc via the following link: https://www.investormeetcompany.com/fusion-antibodies-plc/register-investor\n \nFor those investors who have already registered and added to meet the Company, they will automatically be invited. Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the \"Ask a Question\" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A r...